Punto Health is developing a dementia care platform that combines speech-based digital biomarkers with personalized daily care plans and clinician dashboards to shift cognitive care toward earlier identification and proactive, day-to-day support. The system forms a connected ecosystem that guides patients and carers while streamlining monitoring and care coordination for clinicians. Over the past year, the team co-designed and clinically validated the product with partners such as Ace Alzheimer Center Barcelona, several NHS Foundation Trusts, and multiple Spanish hospitals, reaching more than 2,000 individuals in the process. Feedback from these patients, carers, and clinicians has shaped product features aimed at usability and continuous engagement. With fresh seed capital, the company plans to scale its technology, expand hiring in London and Barcelona, and widen access to proactive dementia care for additional families. Financially, Punto Health has secured $2.7 million to fund these growth initiatives. The company is led by co-founder and CEO Anna Muñoz Farré.

Total raised

$4M

Funding rounds

3

Latest round

Seed

Latest activity

Dec 2025